Neonatal lupus: Long term outcomes of mothers and children and recurrence rate

Clinical and Experimental Rheumatology

Volumn 15, Issue 5, 1997, Pages 467-473

  Brucato, A ^a,d   Franceschini, F ^b   Buyon, J P ^c  

^a OSPEDALE NIGUARDA CA GRANDA   (Italy)

^b SPEDALI CIVILI   (Italy)

^c NYU HOSPITAL FOR JOINT DISEASES   (United States)

^d NONE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; LUPUS ANTICOAGULANT;

ARTICLE; CONGENITAL HEART BLOCK; CONNECTIVE TISSUE DISEASE; HUMAN; LUPUS ERYTHEMATOSUS; MORTALITY; NEWBORN; PACEMAKER; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK;

HEART BLOCK; HUMANS; INFANT, NEWBORN; INFANT, NEWBORN, DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MOTHERS; RECURRENCE; TREATMENT OUTCOME;

EID: 0030886971     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. BUYON JP. Neonatal lupus. Curr Opin Rheumatol 1996; 8: 485-90.
2. REICHLIN M, BRUCATO A, FRANK MB, et al.: Autoantibodies to native 60 kD Ro/SSA and denaturated 52 kD Ro/ SSA are concentrated in eluates from the heart of a child who died with complete congenital heart block. Arthritis Rheum 1994; 37: 1698-703.
3. CAMPBELL M, EMANUEL R: Six cases of congenital complete heart block followed for 34-40 years. Br Heart J 1967; 29: 577-87.
4. BUYON JP, HIEBERT R, CHIN D, et al.: Congenital heart block: mortality, morbidity, and recurrence rates obtained from a National Neonatal Lupus Registry. Arthritis Rheum 1996; 39 (Suppl.): S308.
5. SILVERMAN ED: Congenital heart block and neonatal lupus: prevention is the goal. J Rheumatol 1993; 20: 1101-4.
6. NAKAMURA FF, NADAS AS: Complete heart block in infants and children. N Engl J Med 1964; 270: 1261-8.
7. KANGOS JJ, GRIFFITHS SP, BLUMENTHAL S: Congenital complete heart block. A classification and experience with 18 patients. Am J Cardiol 1967; 20: 632-8.
8. SOULIE P, FOUCHARD J, LAURENS P: Blocs auriculo-ventriculaires congenitaux isoles, de haut degré (aspects evolutifs): à propos de 47 observations. Arch Mal Cour 1970; 8: 1078-87.
9. MICHAELSSON M, ENGLE MA: Congenital complete heart block: an international study of the natural history. Cardiovase Clinics 1972; 4: 85-101.
10. MCCUE CM, MANTAKAS ME, TIGELSTAD JB, RUDDY S: Congenital heart block in newborns of mothers with connective tissue disease. Circulation 1977; 56: 82-90.
11. ESSCHER E, SCOTT JS: Congenital heart block and maternal systemic lupus erytematosus. Br Med J 1979; 1: 1235-1238.
12. KARPAWICH PP, GILLETTE PC, GARSON A, HESSLEIN PS, PORTER C, MCNAMARA DG: Congenital complete atrioventricular block: clinical and electrophysiologic predictors of need for pacemaker insertion. Am J Cardiol 1981; 48: 1098-102.
13. PINSKY WW, GILLETTE PC, GARSON A, MCNAMARA DG: Diagnosis, management, and long-term results of patients with congenital complete atrioventricular block. Pediatrics 1982; 69: 728-33.
14. REID JM, COLEMAN EM, DOIG W: Complete congenital heart block. Report of 35 cases. Br Heart J 1982; 48: 236-9.
15. DEWEY RC, CAPELESS MA, LEVY AM: Use of ambulatory electrocardiographic monitoring to identify high-risk patients with congenital complete hart bock. N Engl J Med 1987; 316: 835-9.
16. MCCUNE AB, WESTON WL, LEE LA: Maternal and fetal outcome in neonatal lupus erythematosus. Ann Intern Med 1987; 106: 518-23.
17. SHOLLER GF, WALSH EP: Congenital complete heart block in patients without anatomic cardiac defects. Am Heart J 1989: 118: 1193-8.
18. NORMAND J, BOZIOA, HEUDRON F, et al.: Pronostic à long terme des blocs auriculo-ventriculaires congenitaux. Arch Mal Coeur 1992; 85: 1403-9.
19. JULKUNEN H, KAAJA R, WALLGREN E, TERAMO K: Isolated congenital heart block: fetal and infant outcome and familial incidence of heart block. Obstet Gynecol 1993; 82: 11-6.
20. WALTUCK J, BUYON JP: Autoantibody-associated congenital heart block: outcome in mothers and children. Ann Intern Med 1994; 120: 544-51.
21. MICHAELSSON M, JONZON A, RIESENFELD T: Isolated congenital complete atrioventricular block in adult life. A prospective study. Circulation 1995; 92: 442-9.
22. BRUCATO A, GASPARINI M, VIGNATI G, et al.: Isolated congenital complete heart block: long-term outcome of children, and immunogenetic study. J Rheumatol 1995; 22: 541-3.
23. YATER WM: Congenital heart block: review of the literature; report of a case with incomplete heterotaxy; the electrocardiogram in dextrocardia. Am J Dis Child 1929; 38: 112-36.
24. GEGGEL RL, TUCKER L, SZER I: Postnatal progression from second-to third degree heart block in neonatal lupus syndrome. J Pediatr 1988; 113: 1049-52.
25. DALVI BV, CHAUDHURI A, KULKARNI HL, KALE PA: Therapeutic guidelines for congenital complete heart block presenting in pregnancy. Obstet Gynecol 1992; 79: 802-4.
26. BRUCATO A: Congenital heart block and mothers immunology. (Letter) Circulation (in press).
27. FROHN-MULDER IM, MEILOF JF, SZATMARI A, STEWART PA, SWAAK TJ, HESS J: Clinical significance of maternal anti-Ro/SS-A antibodies in children with isolated heart block. J Am Coll Cardiol 1994; 23: 1677-81.
28. HUBSCHER O, BATISTA N, RIVERO S, et al.: Clinical and serological identification of 2 forms of complete heart block in children. J Rheumatol 1995; 22: 1352-5.
29. FRIEDMAN RA: Congenital AV Block. Pace me now or pace me later? Circulation 1995; 92: 283-5.
30. MOAK J, BARRON K, HOUGEN T, COHEN M, FRIEDMAN R, PEREZ M, BUYON JP: Congenital heart block: new observations. Arthritis Rheum 1996; 39 (Suppl.): S189.
31. FOX RJ, MCCUISTON CH, SCOCH ED: Systemic lupus erythematosus: association with previous neonatal lupus erythematosus. Arch Dermatol 1979; 11: 340.
32. JACKSON R, GULLIVER M: Neonatal lupus erythematosus progressing into systemic lupus erythematosus. Br J Dermatol 1979; 101: 81-6.
33. WATERWORTH RF: Systemic lupus erythematosus occurring with congenital complete heart block. N Z Med J 1980; 92: 311-2.
34. LANHAM JG, WALPORT MJ, HUGHES GRV: Congenital heart block and familial connective tissue disease. J Rheumatol 1983; 10: 823-5.
35. REICHLIN M, FRUDAY C, HARLEY JB: Complete congenital heart block followed by anti-Ro/SSA in adult life. Am J Med 1988; 84: 339-44.
36. JULKUNEN H, KURKI P, KAAJA R, et al.: Isolated congenital heart block: long term outcome of mothers and characterization of the immune response to SS-A/Ro and to SS-B/La. Arthritis Rheum 1993; 36: 1588-98.
37. WASICEK CA, REICHLIN M: Clinical and serological differences between systemic lupus erythematosus patients with antibodies to Ro versus patients with antibodies to Ro and La. J Clin Invest 1982; 69: 835-43.
38. BRUCATO A, FRANCESCHINI F, GASPARINI M, et al.: Isolated congenital complete heart block: long-term outcome of mothers, maternal antibody specificity and immunogenetic background. J Rheumatol 1995; 22: 533-40.
39. PRESS J, UZIEL Y, LAXER RM, LUY L, HAMILTON RM, SILVERMAN ED: Long-term outcome of mothers of children with complete congenital heart block. Am J Med 1996; 100: 328-32.
40. BRUCATO A, FRANCESCHINI F, FERRARO G, GASPARINI M, DE JULI E: Long term outcome for the mothers with isolated congenital complete heart block: comment on the article by Julkunen et al. Arthritis Rheum 1994; 37: 1261 (letter).